New Cell Marque Antibody Clone: PAX2 (EP235)
PAX2 (EP235) Mouse Monoclonal Antibody Clone
Anti-PAX-2 nuclear expression is seen in 88% of clear cell renal cell carcinomas, as well as 18% of papillary renal cell carcinoma, and 13% of chromophobe renal cell carcinomas.
More recently, O’Connor et al. demonstrated utility in distinguishing ovarian serous papillary carcinoma (anti-PAX-2 positive) from primary breast carcinoma (anti-PAX-2 negative). Anti-PAX-2 has also been used to distinguish hepatocellular carcinoma (anti-PAX-2 negative) from clear cell renal cell carcinoma.
Find out more about Cell Marque PAX2 (EP235) Mouse Monoclonal Antibody Clone here >